Hydroxylamine,O-[[4-[(aminooxy)methyl]phenyl]methyl]-, hydrochloride (1:2)

Suppliers

Names

[ CAS No. ]:
30777-81-2

[ Name ]:
Hydroxylamine,O-[[4-[(aminooxy)methyl]phenyl]methyl]-, hydrochloride (1:2)

Chemical & Physical Properties

[ Density]:
1.183g/cm3

[ Boiling Point ]:
375ºC at 760 mmHg

[ Molecular Formula ]:
C8H13ClN2O2

[ Molecular Weight ]:
204.65400

[ Flash Point ]:
212.7ºC

[ Exact Mass ]:
204.06700

[ PSA ]:
70.50000

[ LogP ]:
2.66980

[ Index of Refraction ]:
1.57

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NC4950000
CHEMICAL NAME :
Hydroxylamine, O,O'-(p-phenylenedimethylene)di-, dihydrochloride
CAS REGISTRY NUMBER :
30777-81-2
LAST UPDATED :
199503
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C8-H12-N2-O2.2Cl-H
MOLECULAR WEIGHT :
241.14
WISWESSER LINE NOTATION :
ZO1R D1OZ &GH 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 7,329,1964

Related Compounds

  • 5-(3-Aminopropyl)-2-methylphenol
  • 2-(5-Bromopyridin-3-yl)propane-1,3-diol
  • 6-(1H-Indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole dihydrochloride
  • 1-(Thiophen-3-yl)piperazin-2-one hydrochloride
  • Oripavine hydrochloride
  • 1-(2-Methoxyethyl)-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine
  • 4-Fluorothieno[2,3-c]pyridine
  • 2-(4-amino-3-methoxy-1H-pyrazol-1-yl)ethanol
  • N,N-diethyl-5-(3-pyridinyl)-2-Furancarboxamide
  • 2-(Bromomethyl)-3-fluorophenylacetic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.